Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Well, we have MANY things to consider after the re

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155000
(Total Views: 665)
Posted On: 03/08/2021 8:05:48 AM
Avatar
Posted By: TechGuru
Well, we have MANY things to consider after the release of the data:

It is VERY difficult to demonstrate statistical significance. This is why many companies don't make it to market.

It is even more difficult to demonstrate statistical significance ON TOP of all other drugs being used with all the patients. Think about it, we need to show that are much-much better when everybody is given the SOC, that is, the BEST drugs in existence, the standard of care.

Yet we did show improvement. Vyrologix (VX) works, imo there has been lots of de-risking for the company with the results obtained.

Management, to a great extent, is NOT responsible for the results of the trial. They take the drug to test through the proper regulatory structure and then the drug performs (or not).

We had a bit of a bad luck with the splits in patient's age. But this is the way it is.

We need to understand the differences between Severe and Critical form the scientific perspective. A drug sometimes finds it easy to help people less sick that more sick. We have found out that ours works better with the very sick. This is golden. However, there must be a "transition", that is, WE SHOULD HAVE BENEFIT IN SEVERE AS WELL there is not a switch from work to not-work. We better understand what happens in this stage.

There is a big difference between outright approval (were statistical significance is the norm) and EUA (were demonstrable benefit in absence of alternatives is the norm). We showed benefit, we are safe, we are backed up for the science in many scientific papers AND the numbers in our CD-12.

It would be criminal not to issue a EUA and keep on gathering data afterwards with the use of the drug. Just criminal.

But I don't want to repeat myself on my opinion of FDA. Hopefully other countries will show more "mental sanity" and care for their own citizens

In regards to next trial we cannot miss the end-point if this is hospital stay. We are completely de-risked in this one.

I am looking forward to hear about Oncology, and NASH (do we really have 40 patients enrolled already ??), plans for LH trial and BLA submission.

We are good ... in spite of FDA.



(14)
(1)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us